Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PinnacleXon Dec 17, 2019 11:44am
73 Views
Post# 30463825

RE:RE:Whose job is it to find institutional buyers?

RE:RE:Whose job is it to find institutional buyers?
SPCEO1 wrote: What moves would you have liked management to make? And/or what moves did that make that youthink they should not have?

Also, some of the claims you noted are facts (large funds selling) and some are not (there has not been any shorting of note). I do know that some of the selling has been margin related (someone in that situation approached us about potentially buying their shares), so that is a fact as well and I suspect there has been much more margin related selling than even what I heard about.

palinc2000 wrote: I am so confused,,,Since over a year there are claims that large funds are selling,that shorts are shorting,that tax sellers are selling ,that margins are being called.that this and that that,,,,
Yet management claims that they are making the righy moves,,
Big disconnect !!
Darn ,,,this is so unfair,,,,




Lol yup here we go again with his stupid margin selling statement hes made it before, the crazy that comes out his mouth at times and he says its fact! Lol Just read the last qs financials all you need not some fanboys blowing hot air what's fact and what might be. Always comes down to eps this company is bleeding money this ceo made stupid statements. We are gonna be a $400 million revenue company we are gonna be Canadas biggest pharma etc all bullsh@t. The guy called one of his drugs old, and attributed that to it not selling. Never have I heard that in the 40 companies I've traded in my time.
Bullboard Posts